Literature DB >> 16220015

In vitro activities of various antimicrobials against Brucella melitensis strains in the Aegean region in Turkey.

Tansu Yamazhan1, Söhret Aydemir, Alper Tünger, Demir Serter, Deniz Gökengin.   

Abstract

OBJECTIVE: To study in vitro activities of three quinolones (ciprofloxacin, levofloxacin, moxifloxacin), four macrolides (erythromycin, dirithromycin, azithromycin, clarithromycin) and doxycycline against 44 clinical isolates of Brucella melitensis.
MATERIALS AND METHODS: Forty-four B. melitensis strains were isolated from blood cultures of adult patients with acute brucellosis who were hospitalized in the clinical ward of the Department of Clinical Microbiology and Infectious Diseases. The minimum inhibitory concentrations (MICs) of the tested antimicrobials were measured by the agar dilution method. MIC90 and MIC50 values were defined as the lowest concentration of the antibiotic at which 90 and 50% of the isolates were inhibited, respectively.
RESULTS: Doxycycline (MIC50: 0.25 microg/ml, MIC90: 0.50 microg/ml) had the lowest MIC in vitro against the B. melitensis strains. Among the quinolones, ciprofloxacin and levofloxacin had similar activities (MIC50: 0.5 microg/ml, MIC90: 2 microg/ml), whereas MIC of moxifloxacin (MIC50: 1 microg/ml, MIC90: 8 microg/ml) was higher than both antibiotics in this group. Clarithromycin and azithromycin were the most active macrolides (MIC50: 8 microg/ml and MIC90: 32 microg/ml), followed by erythromycin (MIC50: 16 microg/ml, MIC90: 32 microg/ml) and dirithromycin (MIC50: 64 microg/ml and MIC90: 64 microg/ml).
CONCLUSION: The results indicate that the conventional agent doxycycline is more active than quinolones and macrolides against the B. melitensis in vitro. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16220015     DOI: 10.1159/000088122

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  10 in total

1.  Monitoring intraventricular vancomycin for ventriculostomy access device infection in preterm infants.

Authors:  Jaya Madhura Parasuraman; Mahableshwar Albur; Greg Fellows; Axel Heep
Journal:  Childs Nerv Syst       Date:  2017-10-24       Impact factor: 1.475

2.  Antimicrobial Effects of L-Chg10-Teixobactin against Enterococcus faecalis In Vitro.

Authors:  Alaa Jarkhi; Angeline Hui Cheng Lee; Zhenquan Sun; Mingxin Hu; Prasanna Neelakantan; Xuechen Li; Chengfei Zhang
Journal:  Microorganisms       Date:  2022-05-26

3.  Antimicrobial susceptibilities of Brucella isolates from various clinical specimens.

Authors:  Yasemin Bayram; Hanifi Korkoca; Cenk Aypak; Mehmet Parlak; Aytekin Cikman; Selcuk Kilic; Mustafa Berktas
Journal:  Int J Med Sci       Date:  2011-03-03       Impact factor: 3.738

4.  In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics.

Authors:  Aun Turkmani; Alexandros Ioannidis; Athanasia Christidou; Anna Psaroulaki; Feidias Loukaides; Yiannis Tselentis
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-10-02       Impact factor: 3.944

5.  Identification and in vitro antimicrobial susceptibility of Brucella species isolated from human brucellosis.

Authors:  Rohaidah Hashim; Norazah Ahmad; Jama'ayah Mohamed Zahidi; B Y Tay; Azura Mohd Noor; Sakina Zainal; Hazwani Hamzah; S H Hamzah; T S Chow; P S Wong; K N Leong
Journal:  Int J Microbiol       Date:  2014-07-10

6.  In Silico Selection and Evaluation of Pugnins with Antibacterial and Anticancer Activity Using Skin Transcriptome of Treefrog (Boana pugnax).

Authors:  Yamil Liscano; Laura Medina; Jose Oñate-Garzón; Fanny Gúzman; Monica Pickholz; Jean Paul Delgado
Journal:  Pharmaceutics       Date:  2021-04-18       Impact factor: 6.321

7.  Efficacy evaluation of some antibiotics against syrian brucella spp isolates, in vitro.

Authors:  Mazen Safi; Ayman Al-Mariri
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

8.  Identification and determination of antibiotic susceptibilities of Brucella strains isolated from patients in van, Turkey by conventional and molecular methods.

Authors:  Mehmet Parlak; Hüseyin Güdücüoğlu; Yasemin Bayram; Aytekin Çıkman; Cenk Aypak; Selçuk Kılıç; Mustafa Berktaş
Journal:  Int J Med Sci       Date:  2013-08-22       Impact factor: 3.738

9.  In vitro synergistic activity of antibiotic combinations against Brucella melitensis using E-test methodology.

Authors:  Selcuk Kilic; Murat Dizbay; Kenan Hizel; Dilek Arman
Journal:  Braz J Microbiol       Date:  2008-06-01       Impact factor: 2.476

10.  Investigation of antibiotic susceptibilities of Brucella Strains isolated from various clinical samples in eastern Turkey.

Authors:  Esra Gültekin; Muhammet Hamidullah Uyanık; Ayşe Albayrak; Selçuk Kılıç
Journal:  Eur J Med Res       Date:  2021-06-16       Impact factor: 2.175

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.